Eventide Asset Management - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 153 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$3,544,000
-3.5%
192,0000.0%0.13%
-14.5%
Q2 2018$3,671,000
+23.9%
192,0000.0%0.15%
+9.4%
Q1 2018$2,963,000
+3.0%
192,0000.0%0.14%
-7.3%
Q4 2017$2,878,000
-5.0%
192,0000.0%0.15%
-12.8%
Q3 2017$3,028,000
-16.5%
192,0000.0%0.17%
-23.9%
Q2 2017$3,625,000192,0000.23%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders